5-azacytidine and arabinosyl adenine for the treatment of acute leukemia

Leukemia Research - Tập 1 - Trang 257-260 - 1977
Gerald P Bodey1, Kenneth B McCredie1, Jeane P Hester1, Emil J Freireich1
1Department of Developmental Therapeutics, The University of Texas System Cancer Center, M.D. Anderson Hospital and Tumor Institute, 6723 Bertner, Houston, TX 77030, U.S.A.

Tài liệu tham khảo

Bergy, 1967, Microbiological production of 5 azacytidine. II. Isolation and chemical structure, Antimicrob. Agents Chemother., 625 Bodey, 1975, Adenine arabinoside in cancer chemotherapy, 281 Bodey, 1974, Therapy of adult acute leukemia with daunorubicin and l-asparaginase, Cancer, 33, 626, 10.1002/1097-0142(197403)33:3<626::AID-CNCR2820330306>3.0.CO;2-5 Bodey, 1976, Clinical studies of β-thioguanine deoxyriboside alone and in combination with arabinosyl cytosine, Med. Pediat. Oncol., 2, 199, 10.1002/mpo.2950020210 Cihak, 1966, Incorporation of 5-azacytidine-4-14C and of cytidine-3H into ribonucleic acids of mouse Ehrlich ascites, tumor cells, Coll. Czech. chem. Commun., 31, 3015, 10.1135/cccc19663015 von Hoff, 0000, 5-Azacytidine—a new anticancer drug with effectiveness in acute myelogenous leukemia, Adv. Pharmacol. Chemother. Karon, 1973, 5-Azacytidine: a new active agent for the treatment of acute leukemia, Blood, 42, 359, 10.1182/blood.V42.3.359.359 Lomen, 1975, Phase I study of 5-azacytidine (NSC-102816) using 24-hour continuous infusion for 5 days, Cancer Chemother. Rept., 59, 1123 McCredie, 1973, The treatment of acute leukemia with 5-azacytidine (NSC-102816), Cancer Chemother. Rept., 57, 319 McCredie, 1975, Survival of adults with acute leukemia, 16, 141 Rodriguez, 1973, POMP combination chemotherapy of adult acute leukemia, Cancer, 32, 69, 10.1002/1097-0142(197307)32:1<69::AID-CNCR2820320109>3.0.CO;2-0 Schabel, 1968, The antiviral activity of 9-β-d-arabinofuranosyladenine (Ara-A), Chemotherapy, Basel, 13, 321, 10.1159/000220567 Vadlamudi, 1970, Effect of combination treatment with 5-azacytidine and cytidine on the life span and spleen and bone marrow cells of leukemic (L1210) and non-leukemic mice, Cancer Res., 30, 362 Vesely, 1968, Biochemical mechanism of drug resistance. VII. Inhibition of orotic acid metabolism by 5-azacytidine in leukemic mice sensitive and resistant to 5-azacytidine, Biochem. Pharmacol., 17, 519, 10.1016/0006-2952(68)90267-0 York, 1966, A proposed mechanism for the action of 9-β-d-arabinofuranosyladenine as an inhibitor of the growth of some ascites cells, Can. J. Biochem., 44, 19, 10.1139/o66-003 Zadrazil, 1965, The structure of DNA from Escherichia coli cultured in the presence of 5-azacytidine, Biochem. Biophys. Acta, 108, 701